Cytosorbents (CTSO) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free CTSO Stock Alerts $0.88 +0.06 (+7.32%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cytosorbents Short Interest DataCurrent Short Volume1,550,000 sharesPrevious Short Volume1,620,000 sharesChange Vs. Previous Month-4.32%Dollar Volume Sold Short$1.34 millionShort Interest Ratio / Days to Cover14.8Last Record DateApril 15, 2024Outstanding Shares54,310,000 sharesPercentage of Shares Shorted2.85%Today's Trading Volume109,450 sharesAverage Trading Volume93,292 sharesToday's Volume Vs. Average117% Short Selling Cytosorbents ? Sign up to receive the latest short interest report for Cytosorbents and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCTSO Short Interest Over TimeCTSO Days to Cover Over TimeCTSO Percentage of Float Shorted Over Time Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. Cytosorbents Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,550,000 shares $1.34 million -4.3%N/A14.8 $0.87 3/31/20241,620,000 shares $1.54 million -3.0%N/A10.8 $0.95 3/15/20241,670,000 shares $1.47 million -2.9%N/A5.7 $0.88 2/29/20241,720,000 shares $1.65 million -1.7%N/A5 $0.96 2/15/20241,750,000 shares $1.77 million -2.8%N/A5 $1.01 1/31/20241,800,000 shares $1.82 million -17.1%N/A5 $1.01 Get the Latest News and Ratings for CTSO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytosorbents and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,170,000 shares $2.16 million +7.4%N/A6.2 $0.99 12/31/20232,020,000 shares $2.24 million +8.6%N/A6.4 $1.11 12/15/20231,860,000 shares $3.18 million -0.5%N/A11.9 $1.71 11/30/20231,870,000 shares $2.24 million +11.3%4.9%18.8 $1.20 11/15/20231,680,000 shares $1.97 million +3.1%4.4%19 $1.17 10/31/20231,630,000 shares $2.51 million +0.6%4.3%23.5 $1.54 10/15/20231,620,000 shares $2.77 million +21.8%4.2%23.7 $1.71 9/30/20231,330,000 shares $2.50 million +9.0%3.5%18.3 $1.88 9/15/20231,220,000 shares $2.42 million +19.6%3.2%18.5 $1.98 8/31/20231,020,000 shares $2.63 million +12.4%2.7%16.8 $2.58 8/15/2023907,700 shares $2.53 million +16.8%2.4%15.7 $2.79 7/31/2023777,300 shares $2.77 million 0.0%2.0%12 $3.57 7/15/2023777,400 shares $2.72 million -10.2%2.0%11.3 $3.50 6/30/2023866,100 shares $3.11 million +1.7%2.3%13.6 $3.59 6/15/2023851,500 shares $3.04 million +5.0%2.2%14.5 $3.57 5/31/2023810,900 shares $2.41 million +1.3%2.1%13.3 $2.97 5/15/2023800,600 shares $2.65 million +19.7%2.1%11 $3.31 4/30/2023669,100 shares $1.64 million +14.1%1.8%8 $2.45 4/15/2023586,200 shares $1.84 million -9.0%1.5%6.4 $3.14 3/31/2023644,000 shares $2.17 million -9.7%1.7%6.8 $3.37 3/15/2023712,900 shares $2.28 million +6.9%1.9%5.7 $3.20 2/28/2023666,800 shares $2.05 million +1.4%1.7%4.9 $3.08 2/15/2023657,600 shares $2.29 million -1.2%1.7%5.1 $3.48 1/31/2023665,300 shares $1.90 million +22.5%1.7%4.9 $2.86 1/15/2023543,000 shares $1.23 million +3.4%1.4%3 $2.27 12/30/2022525,000 shares $813,750.00 -16.1%1.4%3 $1.55 12/15/2022625,900 shares $726,044.00 -10.3%1.6%3.8 $1.16 11/30/2022697,500 shares $976,500.00 +2.7%1.8%4.3 $1.40 11/15/2022679,000 shares $1.04 million +33.1%1.8%4 $1.53 10/31/2022510,200 shares $954,074.00 -2.6%1.3%2.6 $1.87 10/15/2022523,900 shares $833,001.00 -10.4%1.4%3.9 $1.59 9/30/2022584,400 shares $794,784.00 -23.6%1.5%4.3 $1.36 9/15/2022765,200 shares $1.47 million +5.5%2.0%3.6 $1.92 8/31/2022725,500 shares $1.38 million +4.5%1.9%3.1 $1.9055x Gains Instead of 9x Gains (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. CTSO Short Interest - Frequently Asked Questions What is Cytosorbents' current short interest? Short interest is the volume of Cytosorbents shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,550,000 shares of CTSO short. Learn More on Cytosorbents' current short interest. What is a good short interest ratio for Cytosorbents? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTSO shares currently have a short interest ratio of 15.0. Learn More on Cytosorbents's short interest ratio. Which institutional investors are shorting Cytosorbents? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cytosorbents: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cytosorbents' short interest increasing or decreasing? Cytosorbents saw a drop in short interest in April. As of April 15th, there was short interest totaling 1,550,000 shares, a drop of 4.3% from the previous total of 1,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cytosorbents' short interest compare to its competitors? Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Cytosorbents: Lucid Diagnostics Inc. (2.53%), DarioHealth Corp. (4.65%), Daxor Co. (0.62%), Beyond Air, Inc. (8.91%), Carmell Co. (0.18%), Apyx Medical Co. (1.31%), Co-Diagnostics, Inc. (1.45%), SeaStar Medical Holding Co. (6.36%), LENSAR, Inc. (0.73%), Modular Medical, Inc. (0.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Cytosorbents stock? Short selling CTSO is an investing strategy that aims to generate trading profit from Cytosorbents as its price is falling. CTSO shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cytosorbents? A short squeeze for Cytosorbents occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTSO, which in turn drives the price of the stock up even further. How often is Cytosorbents' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTSO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LUCD Short Interest DRIO Short Interest DXR Short Interest XAIR Short Interest CTCX Short Interest APYX Short Interest CODX Short Interest ICU Short Interest LNSR Short Interest MODD Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTSO) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group